These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32684235)

  • 61. Role of the Fibrinogen Degradation Products and D-Dimer in the Differential Diagnosis of Pulmonary Tuberculosis and Community-Acquired Pneumonia.
    Min W; Zi-Feng J; Jian-Lin X; Hao-Hui F
    Clin Lab; 2018 Jan; 64(1):135-140. PubMed ID: 29479876
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders.
    Tiscia GL; Margaglione M
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29844251
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats.
    Inoue A; Koh CS; Shimada K; Yanagisawa N; Yoshimura K
    J Neuroimmunol; 1996 Dec; 71(1-2):131-7. PubMed ID: 8982112
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasma Fibrinogen Performs Better Than Plasma d-Dimer and Fibrin Degradation Product in the Diagnosis of Periprosthetic Joint Infection and Determination of Reimplantation Timing.
    Wu H; Meng Z; Pan L; Liu H; Yang X; Yongping C
    J Arthroplasty; 2020 Aug; 35(8):2230-2236. PubMed ID: 32376167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hereditary Hypofibrinogenemia with Hepatic Storage.
    Asselta R; Paraboschi EM; Duga S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Physiological correction of hereditary mild hypofibrinogenemia during pregnancy.
    Marchi R; Durual S; Pecheux O; Neerman-Arbez M; Casini A
    Haemophilia; 2023 May; 29(3):836-843. PubMed ID: 36757142
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.
    Matrat A; De Mazancourt P; Derex L; Nighoghossian N; Ffrench P; Rousson R; Hanss M
    Thromb Res; 2013 Jan; 131(1):e45-8. PubMed ID: 23199548
    [No Abstract]   [Full Text] [Related]  

  • 68. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intraocular infusate with hemocoagulase for the control of bleeding during vitreous surgery.
    Lee HS; Kim SH; Kim IT
    Korean J Ophthalmol; 1989 Jun; 3(1):6-10. PubMed ID: 2795941
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hemostatic effect of topical hemocoagulase spray in digestive endoscopy.
    Wang T; Wang DN; Liu WT; Zheng ZQ; Chen X; Fang WL; Li S; Liang L; Wang BM
    World J Gastroenterol; 2016 Jul; 22(25):5831-6. PubMed ID: 27433096
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk Factors for Tigecycline-Associated Hypofibrinogenemia.
    Liu J; Yan Y; Zhang F
    Ther Clin Risk Manag; 2021; 17():325-332. PubMed ID: 33888987
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention.
    Xu G; Liu X; Zhu W; Yin Q; Zhang R; Fan X
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):193-7. PubMed ID: 17287638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders.
    Neerman-Arbez M; de Moerloose P; Casini A
    Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family.
    Fager Ferrari M; Leinoe E; Rossing M; Norström E; Zetterberg E
    Blood Coagul Fibrinolysis; 2020 Oct; 31(7):481-484. PubMed ID: 32852326
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pseudo valproate-induced hypofibrinogenemia.
    Breningstall GN; Cich JA
    Pediatr Neurol; 1996 May; 14(4):345. PubMed ID: 8962595
    [No Abstract]   [Full Text] [Related]  

  • 77. Hypofibrinogenemia caused by adrenocorticotropic hormone for infantile spasms: a case report.
    Kamei A; Araya N; Akasaka M; Mizuma K; Asami M; Tanifuji S; Chida S
    Brain Dev; 2015 Jan; 37(1):137-9. PubMed ID: 24735983
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clot waveform analysis in Clauss fibrinogen assay contributes to classification of fibrinogen disorders.
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
    Thromb Res; 2019 Feb; 174():98-103. PubMed ID: 30584960
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
    Kumano O; Ieko M; Komiyama Y; Naito S; Yoshida M; Takahashi N; Ohmura K; Hayasaki J; Hayakawa M
    Clin Lab; 2018 Apr; 64(4):433-442. PubMed ID: 29739066
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.